LEXARIA BIOSCIENCE CORP. Oil and Gas Revenue (Deprecated 2018-01-31)
LEXARIA BIOSCIENCE CORP. (LEXX) reported Oil and Gas Revenue (Deprecated 2018-01-31) of $0 for the 10-month period ending 2014-08-31, per its 10-KT filed 2014-12-09.
Discontinued › Income Statement › Other Income
us-gaap:OilAndGasRevenue · last filed 2014-12-09
- LEXARIA BIOSCIENCE CORP. oil and gas revenue (deprecated 2018-01-31) for the quarter ending 2014-07-31 was $135.86K, a 45.97% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. oil and gas revenue (deprecated 2018-01-31) for the quarter ending 2014-04-30 was $167.84K, a 33.76% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. oil and gas revenue (deprecated 2018-01-31) for the quarter ending 2014-01-31 was $160.10K, a 54.45% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. oil and gas revenue (deprecated 2018-01-31) for the quarter ending 2013-10-31 was $241.09K, a 48.60% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. oil and gas revenue (deprecated 2018-01-31) for fiscal 2013 was $1.10M, a 19.17% decline from fiscal 2012.
- LEXARIA BIOSCIENCE CORP. oil and gas revenue (deprecated 2018-01-31) for fiscal 2012 was $1.36M, a 19.76% increase from fiscal 2011.
- LEXARIA BIOSCIENCE CORP. oil and gas revenue (deprecated 2018-01-31) for fiscal 2011 was $1.13M, a 212.79% increase from fiscal 2010.
- LEXARIA BIOSCIENCE CORP. oil and gas revenue (deprecated 2018-01-31) for fiscal 2010 was $362.47K.
| Period end | Oil and Gas Revenue (Deprecated 2018-01-31) 2 month | Oil and Gas Revenue (Deprecated 2018-01-31) 3 month | Oil and Gas Revenue (Deprecated 2018-01-31) 3 month as first filed | Oil and Gas Revenue (Deprecated 2018-01-31) 6 month | Oil and Gas Revenue (Deprecated 2018-01-31) 9 month | Oil and Gas Revenue (Deprecated 2018-01-31) 9 month as first filed | Oil and Gas Revenue (Deprecated 2018-01-31) 10 month | Oil and Gas Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|---|---|
| 2014-08-31 | $0.00 10-KT · filed 2014-12-09 | |||||||
| 2014-07-31 | $135.86K 10-Q · filed 2014-11-14 | $303.70K derived: sum of 2 quarters · filed 2014-11-14 | $463.80K 10-Q · filed 2014-11-14 | $704.89K derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2014-04-30 | $167.84K 10-Q · filed 2014-06-12 | $327.94K 10-Q · filed 2014-06-12 | $569.03K derived: sum of 3 quarters · filed 2014-06-12 | $820.51K derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2014-01-31 | $160.10K 10-Q · filed 2014-03-12 | $401.19K derived: sum of 2 quarters · filed 2014-03-12 | $652.68K derived: sum of 3 quarters · filed 2014-11-14 | $906.06K derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-10-31 | $0.00 10-KT · filed 2014-12-09 | $241.09K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $492.58K derived: sum of 2 quarters · filed 2014-11-14 | $745.96K derived: sum of 3 quarters · filed 2014-11-14 | $1.10M 10-K · filed 2014-01-24 | |||
| 2013-08-31 | $0.00 10-KT · filed 2014-12-09 | |||||||
| 2013-07-31 | $251.48K 10-Q · filed 2014-11-14 | $504.87K derived: sum of 2 quarters · filed 2014-11-14 | $856.36K 10-Q · filed 2014-11-14 | $1.33M derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-04-30 | $253.39K 10-Q · filed 2014-06-12 | $604.88K 10-Q · filed 2014-06-12 | $1.07M derived: sum of 3 quarters · filed 2014-06-12 | $1.57M derived: sum of 4 quarters · filed 2014-06-12 | ||||
| 2013-01-31 | $351.49K 10-Q · filed 2014-03-12 | $820.53K derived: sum of 2 quarters · filed 2014-03-12 | $1.32M derived: sum of 3 quarters · filed 2014-03-12 | $1.46M derived: sum of 4 quarters · filed 2014-03-12 | ||||
| 2012-10-31 | $469.04K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $963.52K derived: sum of 2 quarters · filed 2014-01-24 | $1.11M derived: sum of 3 quarters · filed 2014-01-24 | $1.36M 10-K · filed 2014-01-24 | ||||
| 2012-07-31 | $494.48K 10-Q · filed 2013-09-10 | $639.34K derived: sum of 2 quarters · filed 2013-09-10 | $888.73K 10-Q · filed 2013-09-10 | $1.15M derived: sum of 4 quarters · filed 2013-09-10 | ||||
| 2012-04-30 | $144.86K 10-Q · filed 2013-06-12 | $394.24K 10-Q · filed 2013-06-12 | $651.05K derived: sum of 3 quarters · filed 2013-06-12 | $978.74K derived: sum of 4 quarters · filed 2013-06-12 | ||||
| 2012-01-31 | $249.38K 10-Q · filed 2013-03-13 | $506.19K derived: sum of 2 quarters · filed 2013-03-13 | $833.88K derived: sum of 3 quarters · filed 2013-03-13 | $1.12M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-10-31 | $256.81K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $584.49K derived: sum of 2 quarters · filed 2013-01-29 | $872.09K derived: sum of 3 quarters · filed 2013-01-29 | $1.13M 10-K · filed 2013-01-29 | ||||
| 2011-07-31 | $327.69K 10-Q · filed 2012-09-12 | $359.62K 10-Q · filed 2011-09-14 | $615.28K derived: sum of 2 quarters · filed 2012-09-12 | $876.96K 10-Q · filed 2012-09-12 | $1.01M 10-Q · filed 2011-09-14 | $1.01M derived: sum of 4 quarters · filed 2012-09-12 | ||
| 2011-04-30 | $287.60K 10-Q · filed 2012-06-07 | $549.27K 10-Q · filed 2012-06-07 | $682.22K derived: sum of 3 quarters · filed 2012-06-07 | $804.69K derived: sum of 4 quarters · filed 2012-06-07 | ||||
| 2011-01-31 | $262.04K 10-Q · filed 2012-03-13 | $394.63K derived: sum of 2 quarters · filed 2012-03-13 | $517.09K derived: sum of 3 quarters · filed 2012-03-13 | |||||
| 2010-10-31 | $132.59K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | $255.05K derived: sum of 2 quarters · filed 2012-01-30 | $362.47K 10-K · filed 2012-01-30 | |||||
| 2010-07-31 | $122.46K 10-Q · filed 2011-09-14 | $229.88K 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |